Nasdaq
$7.30▲ 0.41%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $176.4MShares out 24.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 4d agoPre-market26.10.20 21:004Ownership#●●●
EXAGEN INC.
Exagen Inc. insider Jorey Chernett filed a Form 4 statement of changes in beneficial ownership of securities on October 19, 2026. This filing serves as an official report to the SEC regarding changes in the insider's equity holdings.…more
$7.30+0.41%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 05:524Ownership
EXAGEN INC.
John Aballi, an insider at Exagen Inc., filed a Form 4 report regarding changes in beneficial ownership of securities effective October 16, 2026. This filing serves to disclose the updated holdings of the insider.…more
$7.30+0.41%vs prev closeView filingShare - 5d agoPre-market26.10.19 21:053Ownership
EXAGEN INC.
Exagen Inc. insider Jorey Chernett has filed a Form 3, reporting their initial statement of beneficial ownership of securities. This filing serves as a standard disclosure regarding the insider's equity holdings in the company.…more
$7.30+0.41%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.4Pre-market26.08.04 21:00#●●●
엑사젠(Exagen), 2026년 2분기 실적 발표
엑사젠이 2026년 2분기 재무 실적을 공식 발표했습니다. 투자자들은 이번 실적 보고서의 매출 및 수익성 지표를 통해 회사의 성장세를 확인할 수 있습니다.…more
$7.30+0.41%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 7.28Pre-market26.07.28 22:00
●●●●●●●● ●●●●● ●●●●●●
엑사젠이 향후 개최되는 투자자 컨퍼런스에 참여하여 기업 활동을 알릴 계획입니다. 이번 행사를 통해 투자자들에게 자사의 사업 전략과 향후 비전을 공유할 것으로 보입니다.…more
$7.30+0.41%vs prev close
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report